The mechanism of influence of kaempferol on proline-rich acidic protein 1 (PRAP1) expression after percutaneous coronary intervention (PCI) was investigated based on sini decoction and siwu decoction

Author:

Li Jingjing1,Zhu Danni2,Zhang Weichen3,Tao Songmei3,Fan Guanghui4

Affiliation:

1. Clinical College of Traditional Chinese Medicine, Hubei University of Traditional Chinese Medicine, Wuhan, 430065, Hubei Province, China

2. Department of Rehabilitation Physiotherapy, Wuhan Fifth Hospital, Wuhan, 430050, Hubei Province, China

3. Department of Traditional Chinese Medicine, Wuhan Fifth Hospital, Wuhan, 430050, Hubei Province, China

4. Department of Traditional Chinese Medicine, Pinghu Hospital, Shenzhen University, Shenzhen, 518111, Guangdong Province, China

Abstract

Coronary artery disease (CAD) is a common cardiovascular disease that is characterized by accumulation of fatty deposits. Recombinant Human Proline-Rich Acidic Protein 1 (PRAP1) expression is related to prognosis of patients after percutaneous coronary intervention (PCI). This study will be aimed at the treatment by the traditional chinese medicine Sini Decoction (SND) and Siwu Decoction (SWD), and investigate the influence of kaempferol in dried ginger on the postoperative coronary PCI, and further explore the mechanism of kaempferol on the expression of Proline-rich acidic protein 1 (PRAP1) after coronary PCI. Mesenchymal stem cells (MSCs) were isolated and induced to differentiate into endothelial progenitor cells (EPCs). After identification of EPCs by immunofluorescence and angiogenesis assay, cells were divided into high concentration of SND combined with SWD group, low concentration group, vehicle group, and negative control group. Immunofluorescence and Western blot were used to determine the expressions of β-catenin and GSK-3β as well as PRAP1 in EPCs, whilst cell migration, proliferation and adhesion abilities were assessed. MSCs were positive for CD105 and negative for CD34 and CD45, followed by identification of EPCs with staining. Regardless of concentration, administration of SND plus SWD significantly increased EPC migration and proliferation, but decreased adhesion rate of EPCs (P <0.05). Moreover, high concentration of SND and SWD significantly facilitated EPC growth and reduced cell adhesion (P <0.05). Importantly, the levels of PRAP1 and GSK-3β were elevated, and β-catenin decreased in the presence of SND and SWD, with high concentration achieving more significant alterations than low concentration. EPCs were fluorescently stained and showed proliferative properties and in vitro angiogenesis. Sini Decoction and Siwu Decoction can significantly increase β-catenin expression and decrease GSK-3β and PRAP1 expression after PCI. Sini Decoction and Siwu Decoction can also promote cell migration and cell proliferation, and significantly reduce the adhesion ability of EPCs, so as to increase new blood vessels, improve cardiac function and protect the heart.

Publisher

American Scientific Publishers

Subject

General Materials Science

Reference28 articles.

1. Percutaneous coronary intervention: 2017 in review;Rao;Journal of Interventional Cardiology,2018

2. Growing epidemic of coronary heart disease in low- and middle-income countries;Gaziano;Current Problems in Cardiology,2010

3. Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: A focus on physiology;Cho;Korean Journal of Internal Medicine,2018

4. Catheter-based treatment of coronary artery disease: Past, present, and future;Holmes;Circulation: Cardiovascular Interventions,2008

5. Cardiac catheterization in assessment and treatment of kawasaki disease in children and adolescents;Agrawal;Children (Basel),2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3